Sumitomo Mitsui Trust Group Inc. Sells 1,582,704 Shares of Quantum-Si incorporated (NASDAQ:QSI)

Sumitomo Mitsui Trust Group Inc. lessened its stake in shares of Quantum-Si incorporated (NASDAQ:QSI) by 21.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,965,208 shares of the company’s stock after selling 1,582,704 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 4.18% of Quantum-Si worth $16,106,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. SG Americas Securities LLC raised its stake in shares of Quantum-Si by 12.4% during the fourth quarter. SG Americas Securities LLC now owns 67,588 shares of the company’s stock valued at $182,000 after acquiring an additional 7,470 shares in the last quarter. Abel Hall LLC bought a new position in Quantum-Si in the fourth quarter worth approximately $28,000. XTX Topco Ltd raised its stake in Quantum-Si by 81.3% in the third quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock worth $39,000 after buying an additional 19,651 shares in the last quarter. Barclays PLC raised its stake in Quantum-Si by 210.5% in the third quarter. Barclays PLC now owns 196,826 shares of the company’s stock worth $173,000 after buying an additional 133,438 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Quantum-Si by 6.7% in the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after buying an additional 145,091 shares in the last quarter. Institutional investors own 39.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on QSI shares. Alliance Global Partners started coverage on shares of Quantum-Si in a research note on Friday, February 7th. They issued a “buy” rating and a $3.75 price objective for the company. Canaccord Genuity Group reduced their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, November 13th. Finally, HC Wainwright reissued a “buy” rating and issued a $5.50 price objective on shares of Quantum-Si in a research note on Tuesday, January 14th.

Quantum-Si Trading Up 2.1 %

NASDAQ QSI opened at $1.96 on Thursday. The firm’s fifty day simple moving average is $2.20 and its two-hundred day simple moving average is $1.37. Quantum-Si incorporated has a 12-month low of $0.61 and a 12-month high of $5.77. The firm has a market capitalization of $279.71 million, a P/E ratio of -3.06 and a beta of 2.69.

Insider Activity

In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the business’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the sale, the director now directly owns 1,250,000 shares of the company’s stock, valued at $4,175,000. The trade was a 73.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 30.04% of the company’s stock.

Quantum-Si Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.